![]() |
|
|
Vol. 290, Issue 3, 1347-1355, September 1999
Departments of Psychology (J.H.B., J.H.W.) and Pharmacology (G.W.,
J.H.W.), University of Michigan Medical School, Ann Arbor, Michigan
Intravenously self-administered cocaine produces a dose-dependent
release of adrenocorticotropic hormone (ACTH) and cortisol in male
rhesus monkeys. This study investigated whether the acute disruption of
cortisol and/or ACTH release had any effect on ongoing cocaine-maintained responding. Four hypothalamic-pituitary-adrenal (HPA) axis inhibitors were examined: etomidate and ketoconazole, both
of which are cortisol synthesis inhibitors; astressin, a peptidic
corticotropin-releasing factor (CRF) antagonist that binds
CRF1 receptors predominantly in the pituitary gland; and dexamethasone, a highly selective glucocorticoid receptor agonist whose
long-lasting effects reduce or abolish the endogenous release of ACTH
and cortisol. The reinforcing effects of a range of cocaine doses, with
or without pretreatment with an HPA inhibitor, were evaluated using a
fixed ratio 30 time-out 10-min schedule of reinforcement in six male
monkeys. Blood was sampled before, during, and after self-administration sessions. Self-administration of cocaine increased plasma cortisol and ACTH. Pretreatment with etomidate and ketoconazole dose-dependently inhibited the cocaine-induced rise in cortisol and, at
the highest doses, produced a compensatory increase in ACTH release.
Astressin and dexamethasone attenuated or abolished cocaine-induced
cortisol and ACTH release. Despite the efficacy exhibited by these
pretreatments and the variety of mechanisms by which they inhibited the
HPA axis, there was no evidence for any change in cocaine-reinforced
behavior (response rate or infusion number), an indication that acute
changes in the ACTH or cortisol response to cocaine do not play a
direct role in modulating cocaine-seeking behavior under these
behavioral circumstances.
This article has been cited by other articles:
![]() |
Z. Sarnyai, Y. Shaham, and S. C. Heinrichs The Role of Corticotropin-Releasing Factor in Drug Addiction Pharmacol. Rev., June 1, 2001; 53(2): 209 - 244. [Abstract] [Full Text] [PDF] |
||||